DRMA

Conviction 0Scan · Mon, Aug 10, 2026

Bullish belt hold

DRMA$1.10-0.45%

ResistanceSupportVol 14

Vol MA14 67.58K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Dermata Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.dermatarx.com ↗

Price1.10

Change-0.45%

Gap-1.82%

Rel volume0.62×

Avg volume61.15K

Avg $ vol72.7K

SMA 201.22

SMA 501.25

SMA 2001.79

Price vs 50-12.45%

Price vs 200-38.79%

MA stackbearish

50/200 cross—

Supertrenddown · 1.37

RSI (14)38

MACD hist-0.02

MACD cross—

Stoch %K / %D32 / 34

ADX (14)24

+DI / −DI13 / 24

RSI divergence—

MACD divergence—

ATR %+8.66%

ADR %7.25%

52w high6.46

52w low1.08

From 52w high-83.04%

Above 52w low+1.86%

New 52w highNo

SqueezeOff

Bollinger width27.71%

%B0.14

Donchian pos32.35%

Donchian high1.40

Donchian low0.9509

AVWAP (52w high)2.26

vs AVWAP high-51.65%

AVWAP (52w low)1.10

vs AVWAP low-0.86%

OBV trendDown

Chaikin MF (20)-0.14

Today vs 20d0.62×

Avg vol (14d)67.58K

Avg vol (20d)61.15K

Avg $ vol (20d)72.7K

Market cap—

RS 3m (vs SPY)-21.08%

RS 6m (vs SPY)-51.97%

RS line new highNo

Trend template0/8

Technical rank8.4

1 week+1.86%

1 month-18.28%

3 months-13.10%

6 months-40.16%

1 year-82.81%

YTD-49.77%

P/E-0.59

P/B0.69

P/S—

P/FCF—

EPS-8.16

Div yield—

ROE-117.86%

ROA-101.24%

Debt/Eq0.00

Current7.66

EV/EBITDA0.32

Gross margin—

Net margin—

Rev growth—

EPS growth38.49%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-2.5M

Revenue—

Net income-1.85M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out4.02M

Employees9

ListedFri, Aug 13, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank8.4 / 100

Group rank—

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish belt hold

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DRMA

All disclosures →

No recent disclosed trades by Congress in DRMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DRMA

No recent insider (Form 4) filings in DRMA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DRMA · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.